SEROQUEL is indicated for the treatment of depressive episodes in bipolar disorder ; acute manic episodes in bipolar I disorder , as either monotherapy or adjunct therapy to lithium or divalproex ; for the maintenance treatment of bipolar I disorder as adjunct therapy to lithium or divalproex ; and schizophrenia . Patients should be periodically reassessed to determine the need for continued treatment and the appropriate dose .